High content screening for small molecule, genetic modulators and natural products in cell model to identify protein suppressors.

BrightMol Biotech has developed an innovative high-content, cell-based screening platform designed to accelerate the discovery and validation of new therapeutic molecules. At the core of our approach is LIPS (Light Identification of Protein Suppressors), a proprietary technology that enables a more efficient and informative evaluation of compound activity in biologically relevant systems. By improving the speed, scalability, and quality of experimental data generation, we address key bottlenecks in traditional drug discovery processes, which are often time-consuming, costly, and limited in the depth of information they provide. A key advantage of our platform is the ability to monitor target proteins in real time within living cells, allowing direct observation of their localization, dynamics, and response following treatment. This provides a more physiologically understanding of how candidate molecules interact with their targets, enabling earlier and more informed decision-making in the drug development pipeline, increasing the likelihood of downstream success. We offer specialized screening and validation services to pharmaceutical companies, biotech firms, research centers, and academic institutions seeking advanced and reliable solutions to support their R&D activities. By acting as a partner, we help our clients generate high-quality data and strengthen the robustness of their experimental results. Initial validation activities, including internal studies and early industrial collaborations, have demonstrated the robustness and applicability of the technology in real-world settings. These results support the potential of our platform to become a valuable tool for organizations seeking more efficient and predictive drug discovery approaches. We plan to expand the application of our platform across multiple therapeutic targets and research areas, while continuing to strengthen its scientific validation and broaden its industrial adoption.